Clinical Trials

The intricate dance between viruses and the host cells they infect has always been a subject of intense scientific inquiry. Recent research into SARS-CoV-2, the virus at the heart of the COVID-19 pandemic, has revealed a sophisticated mechanism through which this pathogen manipulates host

Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. Characterized by symptoms such as irregular menstrual cycles, excessive androgen levels, and ovarian cysts, PCOS is also associated with significant metabolic complications like insulin resistance,

The eligibility criteria for semaglutide, a medication that has seen rapidly expanded use beyond its initial approval for type 2 diabetes, reflect broader implications for healthcare policies and pharmaceutical budgets in the United States. Initially, semaglutide was approved by the US Food and

In a significant move towards revolutionizing pediatric care, Little Journey, a digital health startup, has secured £6 million in Series A funding. This development aims to enhance its personalized psychological support platform for children and families interacting with healthcare systems. As a

Groundbreaking research, funded by Cancer Research UK and conducted by teams from the Cancer Research UK Scotland Institute in Glasgow and the University of Birmingham, has uncovered innovative ways to potentially use salmonella bacteria to combat bowel cancer. Historically known for causing food

Johnson & Johnson (J&J) has announced promising topline results from its Phase III ICONIC-LEAD trial evaluating icotrokinra (JNJ-2113) for the treatment of moderate to severe plaque psoriasis in patients aged 12 and older. The study revealed that 64.7% of participants treated with